Kazia Therapeutics Ltd (NASDAQ:KZIA)

5.42
Delayed Data
As of Apr 19
 -0.066 / -1.20%
Today’s Change
1.63
Today|||52-Week Range
6.68
+70.57%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization525.2K478.9K467.9K1.1M
 
 
 
 
 
 
Operating ExpensesGross Income-525.2K-478.9K-467.9K-1.1M
 
 
 
 
 
General Expenses5.7M7.7M10.9M13.2M
 
 
 
 
 
Research And Development2.3M4.9M7.2M8.4M
 
 
 
 
 
Total Operating Expenses6.2M8.1M11.4M14.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.2M-8.1M-11.4M-14.3M
 
 
 
 
 
Extraordinary Charge-495.6K-250.5K0.00-576.4K
 
 
 
 
Interest Expense On Debt655.9K57.2K26.20208.15
 
 
 
 
 
Other Expenses0.001.0M166.3K104.2K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-7.3M-7.4M-10.9M-14.5M
 
 
 
 
 
Income Taxes-313.9K-1.3M-2.1M-6.5M
 
 
 
 
 
Minority Interest-93.1K-139.5K-66.9K0.00
 
 
 
 
Net Income-6.9M-5.9M-8.8M-8.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.6M2.4M4.3M4.7M
 
 
 
 
 
Shares To Calculate EPS Diluted1.6M2.4M4.3M4.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$4.33-$2.49-$2.05-$1.72
 
 
 
 
 
EPS Diluted-$4.33-$2.49-$2.05-$1.72